Who is sponsoring NCT05255497?

NCT05255497 is sponsored by Duygu AKTAR REYHANIOGLU.

What drugs are being tested in NCT05255497?

Interventions in NCT05255497: Biodex Balance Exercise System.

What condition does NCT05255497 study?

NCT05255497 studies Diabetic Neuropathies, Diabetes Mellitus, Exercise Training.

Is NCT05255497 still recruiting?

NCT05255497 is currently completed. Last updated 11 March 2022.

Last reviewed 2022-03-11 · How we verify

NCT05255497

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Sensorial Biodex Balance Balance System Exercises in Diabetic Neuropathy

Completed NA Last updated 11 March 2022

What this trial tests

NA trial testing Biodex Balance Exercise System in Diabetic Neuropathies in 27 participants. Completed in 20 September 2020.

Timeline

2 September 2017

Primary endpoint
10 June 2019

20 September 2020

Quick facts

Lead sponsor	Duygu AKTAR REYHANIOGLU
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	27
Start date	2 September 2017
Primary completion	10 June 2019
Estimated completion	20 September 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Biodex Balance Exercise System

Conditions studied

Diabetic Neuropathies — all drugs for Diabetic Neuropathies →
Diabetes Mellitus — all drugs for Diabetes Mellitus →
Exercise Training — all drugs for Exercise Training →

Sponsor

Duygu AKTAR REYHANIOGLU

Who can join

Adults 45 to 76, any sex, with Diabetic Neuropathies or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examined the effects of balance exercises performed with the Biodex Balance System (BBS) on nerve conduction, sensory symptoms, and muscle strength in patients with diabetes-related neuropathy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Computer-based Balance Exercises on Balance, Pain, Clinical Presentation and Nerve Function in Patients With Diabetic Peripheral Neuropathy: A Randomized Controlled Study.
Reyhanıoglu DA, Yıldırım G, Sengun IŞ, Kara B. · · 2024 · cited 5× · PMID 38825999

Verify or expand the search:

Other recruiting trials for Diabetic Neuropathies

Currently open trials in the same condition.

NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting
NCT06674980 — Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DF · NA · recruiting
NCT06798181 — Neuropathic Pain and Type II Diabetic Patients · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05255497 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duygu AKTAR REYHANIOGLU
Last refreshed: 11 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05255497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing